At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- OxVPS (diagnostic test)
- How long the study runs
- Study runs about 32 months (dates as stated)
- About the drug or intervention
- OxVPS — diagnostic test: Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 200
- Started
- 2023-06-20
- Last checked
- 2024-08
Plain English Summary
What is this study?
- • Testing a new treatment for stroke
- • Clinical study - 200 participants
- • The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with stroke
Where?
- • Abingdon - Abingdon Community Hospital
- • Bishop Auckland - Bishop Auckland Hospital
- • Gateshead - Queen Elizabeth Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties. The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems? Participants will completed the OxVPS and the current gold standards visual perception screening tool.
More detail
This is a non-experimental cross-sectional study. It aims to compare the new screening test OxVPS to the gold standard tests for visual perception difficulties. Patients will be recruited at stroke rehabilitation units at hospitals in the North East of England and in Oxfordshire. Following consent: * Participants will complete the paper version of the Oxford Visual Perception Screen OxVPS (\~15 min). * Participants will complete screening for visual perception problems with a validated screening tool (\~30-120 min). * Participants will complete screening for cognition alterations and sensory vision with validated screening tools. (\~30 min) * Stroke details (time since stroke, severity) and demographic data (age, socio-economic status) will be collected to evaluated representativeness of the sample.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
- ✓Within 6 weeks of confirmed stroke.
Who cannot take part
- ✗Insufficient understanding of English
- ✗Clinical concerns that patient is unable follow simple instructions.
- ✗Clinical concerns that patient is unable to concentrate for 15 minutes.
- ✗No capacity to provide agreement to take part.
See the full criteria
Where Is This Study? (3 UK sites)
Abingdon Community Hospital
Abingdon OX14 1AG, United Kingdom
Bishop Auckland Hospital
Bishop Auckland DL14 6AD, United Kingdom
Queen Elizabeth Hospital
Gateshead NE9 6SX, United Kingdom
How to Get in Touch
Kate Cowen, PhD
Sponsor contactCONTACT
Kathleen Vancleef, PhD
Sponsor contactCONTACT
